Back to Search Start Over

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.

Authors :
Aluri J
Bach A
Kaviany S
Chiquetto Paracatu L
Kitcharoensakkul M
Walkiewicz MA
Putnam CD
Shinawi M
Saucier N
Rizzi EM
Harmon MT
Keppel MP
Ritter M
Similuk M
Kulm E
Joyce M
de Jesus AA
Goldbach-Mansky R
Lee YS
Cella M
Kendall PL
Dinauer MC
Bednarski JJ
Bemrich-Stolz C
Canna SW
Abraham SM
Demczko MM
Powell J
Jones SM
Scurlock AM
De Ravin SS
Bleesing JJ
Connelly JA
Rao VK
Schuettpelz LG
Cooper MA
Source :
Blood [Blood] 2021 May 06; Vol. 137 (18), pp. 2450-2462.
Publication Year :
2021

Abstract

Inborn errors of immunity (IEI) are a genetically heterogeneous group of disorders with a broad clinical spectrum. Identification of molecular and functional bases of these disorders is important for diagnosis, treatment, and an understanding of the human immune response. We identified 6 unrelated males with neutropenia, infections, lymphoproliferation, humoral immune defects, and in some cases bone marrow failure associated with 3 different variants in the X-linked gene TLR8, encoding the endosomal Toll-like receptor 8 (TLR8). Interestingly, 5 patients had somatic variants in TLR8 with <30% mosaicism, suggesting a dominant mechanism responsible for the clinical phenotype. Mosaicism was also detected in skin-derived fibroblasts in 3 patients, demonstrating that mutations were not limited to the hematopoietic compartment. All patients had refractory chronic neutropenia, and 3 patients underwent allogeneic hematopoietic cell transplantation. All variants conferred gain of function to TLR8 protein, and immune phenotyping demonstrated a proinflammatory phenotype with activated T cells and elevated serum cytokines associated with impaired B-cell maturation. Differentiation of myeloid cells from patient-derived induced pluripotent stem cells demonstrated increased responsiveness to TLR8. Together, these findings demonstrate that gain-of-function variants in TLR8 lead to a novel childhood-onset IEI with lymphoproliferation, neutropenia, infectious susceptibility, B- and T-cell defects, and in some cases, bone marrow failure. Somatic mosaicism is a prominent molecular mechanism of this new disease.

Details

Language :
English
ISSN :
1528-0020
Volume :
137
Issue :
18
Database :
MEDLINE
Journal :
Blood
Publication Type :
Academic Journal
Accession number :
33512449
Full Text :
https://doi.org/10.1182/blood.2020009620